These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27678550)

  • 1. A test of the cognitive-enhancing potential of low-dose mecamylamine in healthy non-smokers.
    Yuille MB; Olmstead CK; Wells AK; Hahn B
    Psychopharmacology (Berl); 2017 Jan; 234(1):109-116. PubMed ID: 27678550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
    Roh S; Hoeppner SS; Schoenfeld D; Fullerton CA; Stoeckel LE; Evins AE
    Psychopharmacology (Berl); 2014 Feb; 231(4):765-75. PubMed ID: 24114425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
    Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic receptor modulation of the default mode network.
    Hahn B; Harvey AN; Concheiro-Guisan M; Huestis MA; Ross TJ; Stein EA
    Psychopharmacology (Berl); 2021 Feb; 238(2):589-597. PubMed ID: 33216167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
    Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
    Alvarez-Jimenez R; Hart EP; Prins S; de Kam M; van Gerven JMA; Cohen AF; Groeneveld GJ
    Br J Clin Pharmacol; 2018 May; 84(5):888-899. PubMed ID: 29319910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
    Baakman AC; Alvarez-Jimenez R; Rissmann R; Klaassen ES; Stevens J; Goulooze SC; den Burger JCG; Swart EL; van Gerven JMA; Groeneveld GJ
    Br J Clin Pharmacol; 2017 Aug; 83(8):1676-1687. PubMed ID: 28217868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking.
    Jackson A; Nesic J; Groombridge C; Clowry O; Rusted J; Duka T
    Neuropsychopharmacology; 2009 Jan; 34(2):257-65. PubMed ID: 18418361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.
    Simpraga S; Mansvelder HD; Groeneveld GJ; Prins S; Hart EP; Poil SS; Linkenkaer-Hansen K
    Clin Neurophysiol; 2018 Nov; 129(11):2325-2332. PubMed ID: 30248622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects.
    Hahn B; Shrieves ME; Olmstead CK; Yuille MB; Chiappelli JJ; Pereira EFR; Albuquerque EX; Fawcett WP
    Psychopharmacology (Berl); 2020 Jan; 237(1):219-230. PubMed ID: 31686175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.
    Rezvani AH; Bushnell PJ; Levin ED
    Psychopharmacology (Berl); 2002 Dec; 164(4):369-75. PubMed ID: 12457266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD).
    Potter AS; Ryan KK; Newhouse PA
    Hum Psychopharmacol; 2009 Jun; 24(4):309-17. PubMed ID: 19475630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.
    Voss B; Thienel R; Reske M; Habel U; Kircher T
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S106-10. PubMed ID: 20960003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation.
    Alvarez-Jimenez R; Baakman AC; Stevens J; Goulooze SC; Hart EP; Rissmann R; van Gerven JM; Groeneveld GJ
    J Psychopharmacol; 2017 Feb; 31(2):192-203. PubMed ID: 27927703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotine and mecamylamine on cognition in rhesus monkeys.
    Katner SN; Davis SA; Kirsten AJ; Taffe MA
    Psychopharmacology (Berl); 2004 Sep; 175(2):225-40. PubMed ID: 15112030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain dependency of the effects of nicotine and mecamylamine in a rat model of attention.
    Hahn B; Riegger KE; Elmer GI
    Psychopharmacology (Berl); 2016 Apr; 233(8):1427-34. PubMed ID: 26875755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior.
    Newhouse PA; Potter A; Corwin J; Lenox R
    Neuropsychopharmacology; 1994 Apr; 10(2):93-107. PubMed ID: 8024677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
    Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():204-12. PubMed ID: 26519556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.